Gill Jennings & Every Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Gill Jennings & Every Llp

Patent Number:
Title:
Early Intervention Methods To Prevent Or Ameliorate Toxicity
Opposition Date:
Sep 22, 2022
Patent Number:
Title:
Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The Gla Gene
Opposition Date:
May 31, 2022
Patent Number:
Title:
Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters
Opposition Date:
Dec 29, 2021
Patent Number:
Title:
Suspension Compositions Of Cyclosporin A For Subconjunctival And Periocular Injection
Applicant:
Opposition Date:
Oct 27, 2021
Patent Number:
Title:
Methods And Compounds For The Treatment Or Prevention Of Severe Influenza
Opposition Date:
Sep 30, 2021
Patent Number:
Title:
Vilanterol Formulations
Opposition Date:
Oct 13, 2020
Patent Number:
Title:
Dry Powder Formulations Comprising Vilanterol
Opposition Date:
Oct 12, 2020
Patent Number:
Title:
Fluticasone Furoate In The Treatment Of Copd
Opposition Date:
Sep 16, 2020
Patent Number:
Title:
Medical Delivery Devices Having Low Lubricant Syringe Barrels
Opposition Date:
Jul 22, 2020
Patent Number:
Title:
Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma
Opposition Date:
Mar 11, 2020

Competitors of Gill Jennings & Every Llp

ARVEN ILAC SANAYI VE TICARET A.S.

ALCON INC.

ALLERGAN, INC.

Want to track Gill Jennings & Every Llp?

Feel free to send us a message here and we will get back to you